-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Revenues history and change rate from 2013 to Q2 2025.
- Vitro Biopharma, Inc. Revenues for the quarter ending 31 Jul 2025 was $609K, a 90.3% increase year-over-year.
- Vitro Biopharma, Inc. Revenues for the twelve months ending 31 Jul 2025 was $2.11M, a 13.9% increase year-over-year.
- Vitro Biopharma, Inc. annual Revenues for 2024 was $1.86M, a 5.23% increase from 2023.
- Vitro Biopharma, Inc. annual Revenues for 2023 was $1.76M.
- Vitro Biopharma, Inc. annual Revenues for 2015 was $77.8K, a 35% decline from 2014.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)